Controlled release of doxorubicin from doxorubicin/γ-polyglutamic acid ionic complex

Journal of Nanomaterials

Volumn 2010, Issue , 2010, Pages

  Margaritis, Argyrios ^a   Manocha, Bhavik ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC PH; ANTICANCER DRUG; CATIONIC DRUGS; COLLOIDAL AGGREGATES; CONTROLLED RELEASE; DOXORUBICIN; DRUG CARRIER; HYDROLYTIC DEGRADATION; IN-VITRO; IONIC COMPLEX; IONIC INTERACTION; MALIGNANT TISSUES; NEUTRAL PH; PHYSIOLOGICAL BUFFERS; POLYGLUTAMIC ACIDS; SOLUTION PH; THERMAL ANALYSIS; TRIGGERED RELEASE;

ACIDS; COMPLEXATION; DRUG INTERACTIONS; DYES; IONIC DRUGS; PHOTODEGRADATION; SCANNING ELECTRON MICROSCOPY; THERMOANALYSIS; X RAY DIFFRACTION; X RAY DIFFRACTION ANALYSIS;

IONIC STRENGTH;

EID: 77953513117     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2010/780171     Document Type: Article

References (26)

1. Feng S., Chien S., Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases Chemical Engineering Science 2003 58 4087 4114
2. Moghimi S. M., Hunter A. C., Murray J. C., Long-circulating and target-specific nanoparticles: theory to practice Pharmacological Reviews 2001 53 283 318
3. Manocha B., Margaritis A., Production and characterization of γ-polyglutamic acid nanoparticles for controlled anticancer drug release Critical Reviews in Biotechnology 2008 28 83 99
4. Von Hoff D. D., Rozencweig M., Piccart M., The cardiotoxicity of anticancer agents Seminars in Oncology 1982 9 23 33
5. Singal P., Iliskovic N., Li T., Kumar D., Adriamycin cardiomyopathy: pathophysiology and prevention FASEB Journal 1997 11 931 936
6. Goldstein L. J., Galski H., Fojo A., et al.,Expression of a multidrug resistance gene in human cancers Journal of the National Cancer Institute 1989 81 116 124
7. Janes K. A., Fresneau M. P., Marazuela A., Fabra A., Alonso M. J., Chitosan nanoparticles as delivery systems for doxorubicin Journal of Controlled Release 2001 73 255 267
8. Kalaria D., Sharma G., Beniwal V., Ravi Kumar M., Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats Pharmaceutical Research 2009 26 492 501
9. Papagiannaros A., Hatziantoniou S., Dimas K., Papaioannou G. T., Demetzos C., A liposomal formulation of Doxorubicin, composed of hexadecylphosphocholine (HePC): physicochemical characterization and cytotoxic activity against human cancer cell lines Biomedicine Pharmacotherapy 2006 60 36 42
10. Dreis S., Rothweiler F., Michaelis M., Cinatl J. Jr., Kreuter J., Langer K., Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles International Journal of Pharmaceutics 2007 341 207 214
11. Gabizon A., Shiota R., Papahadjopoulos D., Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times Journal of the National Cancer Institute 1989 81 1484 1488
12. Missirlis D., Kawamura R., Tirelli N., Hubbell J. A., Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles European Journal of Pharmaceutical Sciences 2006 29 120 129
13. Kwon G. S., Naito M., Yokoyama M., Okano T., Sakurai Y., Kataoka K., Physical entrapment of adriamycin in AB block copolymer micelles Pharmaceutical Research 1995 12 192 195
14. Couvreur P., Kante B., Grislain L., Roland M., Speiser P., Toxicity of polyalkylcyanoacrylate nanoparticles. II: doxorubicin-loaded nanoparticles Journal of Pharmaceutical Sciences 1982 71 790 792
15. Akiyoshi K., Taniguchi I., Fukui H., Sunamoto J., Hydrogel nanoparticle formed by self-assembly of hydrophobized polysaccharide. Stabilization of adriamycin by complexation European Journal of Pharmaceutics and Biopharmaceutics 1996 42 286 290
16. Teng X. R., Shchukin D. G., Möhwald H., A novel drug carrier: lipophilic drug-loaded polyglutamate/ polyelectrolyte nanocontainers Langmuir 2008 24 383 389
17. Vishweshwar P., McMahon J. A., Bis J. A., Zaworotko M. J., Pharmaceutical co-crystals Journal of Pharmaceutical Sciences 2006 95 499 516
18. Jimenez-Kairuz A., Allemandi D. A., Manzo R. H., The improvement of aqueous chemical stability of a model basic drug by ion pairing with acid groups of polyelectrolytes International Journal of Pharmaceutics 2004 269 149 156
19. Guo B., Yuan J., Gao Q., pH and ionic sensitive chitosan/carboxymethyl chitosan IPN complex films for the controlled release of coenzyme A Colloid and Polymer Science 2008 286 175 181
20. Agresti C., Tu Z., Ng C., Yang Y., Liang J. F., Specific interactions between diphenhydramine and -helical poly(glutamic acid)a new ion-pairing complex for taste masking and pH-controlled diphenhydramine release European Journal of Pharmaceutics and Biopharmaceutics 2008 70 226 233
21. Li C., Poly(L-glutamic acid)anticancer drug conjugates Advanced Drug Delivery Reviews 2002 54 695 713
22. Buescher J. M., Margaritis A., Microbial biosynthesis of polyglutamic acid biopolymer and applications in the biopharmaceutical, biomedical and food industries Critical Reviews in Biotechnology 2007 27 1 19
23. Manocha B., Margaritis A., A novel method for the selective recovery and purification of γ-polyglutamic acid from Bacillus licheniformis fermentation broth Biotechnology Progress 2010 26 3
24. Urva S. R., Shin B. S., Yang V. C., Balthasar J. P., Sensitive high performance liquid chromatographic assay for assessment of doxorubicin pharmacokinetics in mouse plasma and tissues Journal of Chromatography B 2009 877 837 841
25. Khachatoorian R., Petrisor I. G., Yen T. F., Prediction of plugging effect of biopolymers using their glass transition temperatures Journal of Petroleum Science and Engineering 2004 41 243 251
26. Ho G., Ho T., Hsieh K.,et al., γ-polyglutamic acid produced by Bacillus subtilis (natto): structural characteristics, chemical properties and biological functionalities Journal of the Chinese Chemical Society 2006 53 1363 1384